ÂÜÀòÂÒÂ×

Jesse Lieberman has a diverse background in the medical field, with experience spanning from 2009 to 2023. They began their career as a Physical Medicine and Rehabilitation Physician at Carolinas Rehabilitation, where they worked as an attending physician and conducted research. They were promoted to Assistant Professor in September 2012 and later promoted to Associate Professor in January 2019. During their time at Carolinas Rehabilitation, they primarily treated inpatients and managed an outpatient clinic population, focusing on patients with spinal cord injuries and various other disabilities.

In 2022, Jesse Lieberman served as the Medical Director at NeuroRestorative. They then worked as the Chief Medical Officer at Palmetto GBA from April to July 2023.

In the latter half of 2023, Jesse Lieberman held multiple positions simultaneously. They served as the Medical Director at Theoria Medical and worked as a Supervising Physician at both Kinetic Medical Group and Lightyear Health. They also served as a Physical Medicine and Rehabilitation Physician at Dane Street.

In 2022, Jesse Lieberman worked as a Physical Medicine and Rehabilitation Physician at Veterans Evaluation Services, until April 2023.

Overall, Jesse Lieberman has held various leadership positions and gained substantial experience in physical medicine and rehabilitation, while also contributing to research in the field.

Jesse Lieberman has a diverse education history. In 1999, they obtained a Bachelor's degree in Zoology/Animal Biology from North Carolina State University. Jesse continued their education at the same university, earning a Bachelor of Science in Zoology in 1999. Jesse later pursued a Doctor of Medicine (MD) degree from the Wake Forest University School of Medicine, completing their studies from 2000 to 2004. In 2013, they obtained a Master of Science (MS) in Public Health from the University of North Carolina at Charlotte. Jesse recently obtained certification as a Medical Doctor from the North Carolina Medical Board in June 2021.